Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

10-week, Open, National, Multicenter Clinical Trial to Evaluate the Safety of Insulin Glargine in Type 2 Diabetes Mellitus Patients, on Intensified Conventional Therapy (ICT)

NCT00354939 is registered in ClinicalTrials.gov with Sanofi as lead sponsor.

NCT NCT00354939
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00354939 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
10-week, Open, National, Multicenter Clinical Trial to Evaluate the Safety of Insulin Glargine in Type 2 Diabetes Mellitus Patients, on Intensified Conventional Therapy (ICT)
Lead sponsor
Sanofi
Phase
Phase 4
Overall status
Completed
Start date
October 31, 2003
Completion date
March 31, 2004
Enrollment
480
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

diabetes mellitus type 2